SECCIONES IV-V- VII: VIH/SIDA
SECCIÓN IV – Alcance de la propuestaTabla IV.23 ! " # " " " " $ " % & " " " ' ( ) " " !"% * " " " & +,+- ./ / & 0 " 0 1" 2 # $ " 3 4 " & $" 3 % " & ! " % 1" & % 5 " * " ! " % " " " " " % " " "5 " & " * # % & 3 ! % ! " 0 " & ! " ! " 67*5 " & ! 8 " " ) " " 0 2 # !%& '( $ * & 0 " " , % " - 5 % 0 1 " , & &" " " ! " " % " % " 7 2 " " !%& '($" " " ! 3 1 " #" % 5% " +/9 * 2
, * ! " &" " &: ! " " &3 " % &" " 3 " & 7 " " " +/9 % &" 1 % " 1 & 5%3
" " 2 . " " +/9 %
)*
Tabla IV.25 " ) <= <= ><<? ) ?= => ><<@)
'
+,
-(+-,-(+
)
.
/
0
; " % A & " " " 0 ! " " % " ! B% 1 1 ! " &" " & ! 3 ! % % " " " , 3 " ' $ = " " 3 *" 8 3 " 3 &" " " % & " "3 5> ; 7* " * & 1 !5? 0 0 " 0 0 " 5 C , 0 8 & " &" % %" * " "5( 0 1 " , %+/9 1 " 80 " " " " " 0 % " ! % ! " " % " & 2 2>D2= .1-( ! /.-; ;+ ; ,-+9- E/ ; , F ; , + ; /G E/,+-,23 /4 5 0 / ( 6 0 (5 )** (5 )**7 , & " ;# " ?<H , & " *" 8 ;# " ?<H , & " " " =( =I ) ;# " ?<H , " " " ;# " (<H , * ) " &: " ! " 6 ) <2?H <2<(H))
,23
#
--+;;-,-+F + G+ ;J + /,+ ; +/ +/,- - 9 + F F+ / ,+ ; E/ .;/ - ; ,+- .9 / -+3 F + ; +/ ;G/ - . -; ,- - 9+, - ; /G E/,+-&: " +/93 ' % * & % " 0# " *2 " ! 3" 0" " 3 *" 8 % & ! 0: 3 " " % & " " % " " " % "#0 " * & " 3 " " 3" ' 8 " 03 * " " 7 7 % " " " , 2 D<H " % 1 ' % C<H 2 * ! " % 3 +/9K 0 ' : % " & +/9 * 5 ' +/9 * " " 7 2 , # 3 GG 3, # % ! " - 7 ! &" " " " ' " 3 % " & ! 3 ' &" " * 2 ; " ' " " ! " " 0 " % 2 Tabla IV.27 ,891- , --+;;-,-+F + G+ ;J + /,+ ; +/ +/,-- 9+ F F+ / ,+ ; +/ .;/ - ; ,+- . 9 / -+3 F + ; +/ ;G/ - . -; ,- - 9+, -; /G E/,+- 2 % 2 ,23 / ( 6 0 (5 )**: (5 ) (5 : (5 ; (5 < , * " 7 "! ! 8 ' 7 2 ;# " (H L =<H L ><H L ?<H L , * " 7 ! "! ! 8 2 ;# " (H L =<H L ><H L ?<H L , * " ! "! 4 ! 8 " * 2 ;# " (H L =<H L ><H L ?<H L , * " * " : " " & ! 2 (<H (HL =<HL >(HL ?(HL(
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
* Constituirá, conjuntamente con otros elementos que se mencionarán en otros objetivos, la línea de base del presente proyecto.
** Dependiendo del nivel de complejidad , características del proyecto y tamaño de la población beneficiaria, podría reducirse el número de proyecto e incrementarse el monto estimado para cada uno de ellos
>2 G+- ; -; O . E/ ;,;// +/ ; . E/ ; . ; F ; +- ,;/ / ; .-- .;. 9 / . + ;+ / -+ . +/ P F ;;- +3 / . + , 9E9 + , /+ F ;/9. G/ - . - ; ,- - 9+ , - / - ;+ +; / +;-J + 2 " I2IH &" 8 =( ) 3 * 7 C@H =I ) / / IC 5 =3(H " " 1 "! C(H &
! " % / / II2 &: " * & " " ! # " " " " & * A;% " " ! 8 % B% A;% , & ! % 0 " B3" " " ! 3 " " ! 8 % & ! " 2 , 3 * 0 " !0 % " " ,;/ " " ! 8 Q,;/ 6 % % ! " & 4 % &" 3 0 ! " & ! " 3" 7 7 % " " " , 2 Tabla IV.27 ,891- , ) G+- ; - ; O . E/ ; ,;/ / +/ ; . E/ ; . ; F ; +- ,;/ / ; .-- .;. 9 / . + ;+ / -+ . +/ P F ;;- +3 / . + , 9E9 + , /+ F ;/9. +/ ;G/- . -; ,-- 9+, - / - ;+ +; / +;-J + 2 % 2 ,23 / ( 6 0 (5 )**: (5 ) (5 : (5 ; (5 < , * " " " ! ' 3 7 3, , " " " ! 8 ! & ! " %" 7 7 2 =H ><H (<H @(H I<H , * " " "! " & ! C(HM L=<H L><H L?<H L?(H , * " " " " ! ;# " ><H ?<H C<H D<H , * " " 1 "! ! 8 " 0 ' 2 ;# " =<H L ><H L ?<H L ?(H L , * " " ! "! ! 8 2 ;# " =<H L =(H L ><H L >(H L
(
) 1 #+(=1&( ,=>C 3 #+(=1&( ,;/ ' " " ) ><<< % 7 " " 0 " ! % " ! 3 7 " " * ( & 2 7 & * % * & 3 0 " % ' " & ! " 2 , 3" ' " 8 % " " &: " % " " +/9K2 )) (3 $ 5 ' " & ! " 0 3 0 %" " " &2 ): " 0 " " &" " 1 ' " 0# & 3 " ! " " ! & 2 ); 1 8? $8 D -A & $ # # 8 E 3 2 !%& '(F -& , " ' %" ' 0 # 3 " " * % " & " )" ! " % " ! 2 , % * ! " 3 1 ' & 0 " " & " 3 " 1 ' " 1" % " 2 )< ' # &" " ": 3 0 1 ' " " % " " ! 2 " ? % C " & ' " 3% " " & ' ?< 0 2 ; " " " &" " ' ,;/ 2 ; % ' " & ,2Tabla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
?2 G ; - ; + ; ,+ ; E/ / -+ - + +/ O-S F ,-. +;./ - +/ ; G/ ,; - ; + ,-. 9/E F +/ O-S ; " & " * # % & 3 * ' " 1* " ' " ' % , 2 ; 8 " " ' 8 " 3 8 : " 0 1 0 " " ! " " ,4 3 ! " ! ' " 0 %& 0: % " "2 &: ! " ?N " * #% & 3" " =N " ( & " % >< & " " #2 ; " " " " & ' 0" * " " " 4 % &" * " 10 " " 1" " " " 9 % 2 Tabla IV.27 ,891- , : G ; - ; + ; ,+ ; E/ / -+ - + +/ O-S F,-. +;./ - +/ ;G/ ,; - ; + ,-. 9/+ F +/ O-S % 2 ,23 / ( 6 0 (5 )**) (5 ) (5 : (5 ; (5 < /4 " " * #% & " # & > =( >< >D ?N , * " " * # % & 8 3 0 " +/9 =<<H N<H N<H N<H N<H
(
: & ,=> 3 ? 3 B 2 $ .&# , ! " +/9 * ' " * # % & 3 " ' 7 " * %" " " " " 7 2:) 3 B 2 / # 0 , " 0 ! " ! &: ! " & " 1*3 )" " " * #3 0 1 " 2 " * # % & N<H " ' *" +/9 % ><H ' 0" & 4 &" " 2 " " ' * " % 1 ' % % ' " ! 2 ; " " " & '" " & 0 " " 0#2 :: G 2 42 @ 2 ! " " " " " " " / " 0 ; " 1 ,: 13 ! # " & 2 " " " " >> & " # %" ? " 0 T 3 % 9 % 5: 4 % " 2 % 6 " " 4 % " " & ? " 0 " " 5 1 % & : " * " " " " 0 ! % " , 3 0 " 0 # " " " 4 %" & " 0 " #2 Tabla IV.27.1 ,891- , : G ; - ; + ; ,+ ; E/ / -+ - + +/ O-S F ,-. +;./ - +/ ;G/ ,; - ; + ,-. 9/+ F +/ O-S ( % ,23 , / 0/ ( 6 0 /1 5 0 )**) (5 (5 ) 2 % 3 ?2= ! " +/9 /4 " +/9 " 2 < =< ( , ?2>2 ! " & " * #% & 2 /4 " " , " % " 2 > =< ( +/9 " ?2?2 G " " " 4 % " 0 1 ! " 2 /4 " 0 % & " " 4 " " " & " *" "2 (H (<H =<<H ,Q " 0
C2 ,; -; + - .- ; / O+ / -E + ; ; " " & " " ' " " " 3 " * " ! ' " " " " " & " ! 2 , * " ! " ! " 2 ; ;%" " " 9 " " " " 7 2 ; ' & 7" & " * # 2 Tabla IV.27 ,891- , ; ,; -; + - .- ; / O+ / -E + ; % 2 ,23 / ( 6 0 (5 )**) (5 ) (5 : (5 ; (5 < /4 " " " " " 1 * " ! " 2 =<H >(H ?(H (<H @<H , * " " & 1 2 <H ><H ?<H (<H @<H
(
; 3 -& , 7 ! ! % " ! 8 3 ' " " * " ! % * #3 1 ' % # & 4 % &" 2 ;) 2 ! , 0 1 " 7 " " " " 1 ! " !0 3 " ' " & " & ' ! " " " ! % ' ' " 0'" 1 2Tabla IV.27.1 ,891- , ; ,; -; + - .- ; / O+ / -E + ; 2 ( % ,23 , / 0/ ( 6 0 /1 5 0 )**) (5 (5 ) 2 % 3 C2=2 ! " " " * " ! " % * # , * " " " " " " * " ! (H ><H (<H , O9GG , # +/9 C2>2 ) ! " " ! & " " " )" " / =<<H / , O9GG , # +/9 (2 O+- -; ,+/ ; +/ +/ , * 2 1 ' " ! 3 " 0 4 37 3" 3 # 3 " 3 ' " " 0 " " " ! " " 3 3 " " " " " ' &: " 2 " ' ' & % 1 ! " 0 " 0 " 0 " " " 0 1 " "2 , " 3 0 & & " ' " * 3 ! * &3 " & 2 / 8 " ! " " & +/9 1 " " 2 Tabla IV.27 ,891- , < O+- -; ,+/ ; +/ +/ % 2 ,23 / ( 6 0 (5 )**) (5 ) (5 : (5 ; (5 < , * " 0 4 M3 " " ! " " 0 <H C<H D<H N<H I<H
(
< 1 2 , " 0 4 " 8 " " " ! " " 3 ' & " " " 0 " 7 2 <) = @ " " * " " " ' 0 " " " " " " 0 4 % " " ' &: " 2 " '% " " ' " " " '" % 0 2 Tabla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
" " " " !
1" 2
=<H (<H I<H I<H I<H
, * " * 1" " 3 " " 4 % &" " 3 - 8 ! " 67* ;# " (<H LN<H D(H LI<H @(H LI(H N<H LI(H
(
H 42 & " ! " & " ! ' " " " " ,%" 7% " 1 3 " " & " ! " " " " " "2 , " 1" 3 " ' " ! % ' " " " & 3 " ' 1 ' &" " " 0 % & !2 ! " ' 7 & % % " ! " 2 H) 5 $ 2 F 5 . ) " ! '$ 1 ! % 0 " 4 5%3 " * 8* % 8 " 2 Tabla IV.27.1 ,891- , H G+- ; -; / E/ -/+6 /G / ;, - /.-; - / E/ ; ; - Q O+ ( % ,23 , / 0/ ( 6 0 /1 5 0 )**) (5 (5 ) 2 % 3 D2=2 ! " " " " 4 % &" " 3 " 04 2 , * " " " " 2 10% 50% 75% , GG O9 D2>2 ) " ! " 3 0 % & , * " 1" " 1* " 4 % &" " 0.3% 50% 100% 65% 100% ,#
@2 +G- - ; , 3 / E/ / 9- ;T. / ;.F ; / - 9 - 2 " " " " & ' " " & " " 0 " " % ! 3 " % 3 " ' " ! " % 2 " " ' 0 " ! ' " % ' " ! " % ! " & 3 " & " % ! " " " 2 ; ! 0 ' ! :" 3 !0 3 " !0 % * #2 Tabla IV.27,891- , 7 OFERTAR A LAS PVVIH, ATENCIÓN INTEGRAL T. / ;.F ;
/ - 9 - 2 % 2 ,23 / ( 6 0 (5 )**) (5 ) (5 : (5 ; (5 < , * " , M " ! " & " " ><H " ?<H (<H @<H N<H , * " , - 3% 04 ><H @<H N<H I<H I<H , * " , 8 " " " " %
><H I<H I<H I<H I<H
* el denominador será el total de casos notificados (vivos)
7 4 3 B$ $ $ # !$ , 0 1 " 0 ! % 6 % " " && " 3 1 ' 7 8 '" " " & " ! " & " " 2 , 3 " ' " * #3 " 0 ! % % 3 * % " " ' " " 3 ! " % " & 7 & % " " "2 " " ! ' 1 " " % 0 1 " 7 " , 3 " " "5 " ' +/9% , 2
7) G D 42 2 @ , 7 & ' " " :" 3 3 ! 0 3 *" 3 ! 0 3 " %0 ! 0 % & '" " 3 " ! 3 0 " " % " " 3 " - 3 ! 0 " , 2 7: ' !%& '( ( $ 4 " ><<> , &: 0 " - 3 8 " ><< 4 " &: " & " 0 " " 3 # (<H " 4 " 2 U " : " 0 3 ' " " " - 2 0 # " ! ' 1" > & )3 " ' - 2 % " 1 ' " & ' 0 " " 2 7; G 2 , " " " , 3 ' " T %9 % " " 1 0 " C % 8' " 0 & 2 7 ' " " ! " * 0 " C ' " 9 % 2 7< ' # ! D # ! , 0 " ! 0 " " 3 " " "7 3 ' " " , & " 2 ; 0 1 ! % ! " , ' 1" &: " % # * " +/9 2 &" " : " * & N2
Tabla IV.27.1 ,891- , 7 +G- - ; , 3 / E/ / 9- ;T. / ;.F ; / - 9 -( % ,23 , / 0/ ( 6 0 /1 5 0 )**) (5 (5 ) 2 % 3 @2=2 ! " " 04 & " ! $ * 3 " 0 3 ! " "3 & ! % " , % ! " % " " " , * " " " " " " <H ><H (<H , O9 @2>2 G " 7 & 4 % &" " " ! 1" 2 /4 " 7 & " " " ! 1" 04 2 D" (< =< >< , O9 @2?2 ! " - 3 " " " " " " " 2 , * " , % -(<HM @(H N<H , O9 @2C G " " 2 ; " " % " " 1 " C % 0 & 2 < ? , @2(2 0 ! " , " % % "7 , -+ O +N , +/9 * Porcentaje estimado
N2 G+- ; -;+ / + 9 ; F , - , E/ . / ; , 2
; ! " " " & & *" &: " & " 0 " ! " * " 2 ; 0 1 " , 3 0 " " " " 0 3 ' " " " %&0 " " " &" " 0 " 30 1'" " ! " % " & " " " " "2 ,891- , G+- ; - ;+ / + 9 ; F , - , E/ . / ; , 2 % 2 ,23 / ( 6 0 (5 )**) (5 ) (5 : (5 ; (5 < /4 " 0 1 " , " % " " -( =< =< =< =< , * " 0 1 " , " 3 1 " &" " " Q % D<H @<H N<H N<H , * " 0 1 " , 3 1 " &" " " 0 % " ! % 0 0 < =<H >(H C<H D<H
(
& ,=> # ! , % 0 1 ! " 0 " , 3 ' % * ' % " : " +/932 ; " " " &" " '" , ) @ # ! ; % ' " 0" , 3 3 * #3 " !3 " "3 " 10 3 " " # %" 7 7 2 3 % " ' " *: 1 2 3 2 3 @ # ! ; " * * * ' " 0 " ) % ' " 0" % , % " " !3 0 " "3 " ! 3 * %&& " 2 ,891- , G+- ; -;+ / + 9 ; F , - , E/ . / ; , 2 ( % ,23 , / 0/ ( 6 0 /1 5 0 )**) (5 (5 ) 2 % 3 N=2 ! " % " +/9 % , 2 , % " < > , N2>2 ! " % " % 0 1 " , /4 " % " 0 1 " , " = ( N +/9 N2? ! % * ! " " * * , % +/9 , * " 0 1 " , " * * '" 2 <H D<H , %+/9
#
!%& '(
I2 / +-,+- -; ,-+ ; P ; / ; 9 / ,U ; ; ! " ' " ' " " " ' 2 " # 0 " " " ! " " " % * " ' % " 0 1 " 3 % ' " % 0 " *2 * / " " +/ % * ; " "3 & ' " " & " "3 " 3 & " " 3 " " &30 3 ' ! " ' * " 2 0 " ' '" ! & " " & 3 " & %* #" 0 &: " !" 3 # " > &
)2 ; &" " " * & ' " &" " " 0 " " 2 ,891- , / +-,+- -; ,-+ ; P ; /; 9 / ,U ; % 2 ,23 / ( 6 0 (5 )**) (5 ) (5 : (5 ; (5 < " 0 1 " , / " =<H L ><H L ?<H L (<H L " " 0 1 " " && 2 >H =(H ?<H (<H @<H , * " , " " ! " " " & % 2 / " =<H ><H ?(H (<H & 2 @ 2 ,=(&( 3 + & $ !%& '( " 0 +/ % * ; " "3 0 " & 7 % * ! " &" " % % " % & " " 7 7 " , 3 1 ' " 1 !
) $ 3 B % % ' ! " " " ! & " " &3 " & %* #" 0 3 " 1 % " # " ! , % " " &" " & & " ! 2 ,891- , / +-,+- -; ,-+ ; P ; /; 9 / ,U ; ( % ,23 , / 0/ ( 6 0 /1 5 0 )**) (5 (5 ) 2 % 3 I2=2 1 ! % ! " +/ % * ; " "2 /4 " * " 2 < =< >< +/ Q +/9 I2>2 ! " " $ " &3 " & % * #" 0 G &" " < > C +/ 6 +/9
):
.
!%&
'(
2
$
6
$
4 ) 3 " 7 " " & % " " " " " =IN@ ! " , 0 / " 6 ,/ 3 :/ " , & ! 3 % ! " Q +/ 3 " ! ) ><<= " # 3 1 " " &0 " !0 3 '" 0 # !3 3 1" 3 8 " ! " 67* % " - 2 % ) * " #3 +0 1 / 9 " &" " " & ! 0 # 3 *" 8 3 " 2 % " , 0 8 3 " # " ! & " " " " " &3 " ' & 1 ! " " " 7 7 2);
'
2 2
/
?
B
0
);
+
2
!%&
'(
; && " " 0 * & " $ 3 " 80 " " " " 3 " " " 3 ! " " 3" " " 7 7 2 0 0 1 " % 0 1 &" " " & ! 3" 1 ! 5 & 1 ) 3 % , " " 7 2);)
#
" " " " " 3 0 % % " & " " % 0 " " 0 ! " " 2 ; " " & &: " 0 0 1" " % 0 1 0 1 ' % % 0 " & ! %" % ! 0 5 " ' ' " 80 " " " " 2);:
(
A
7 " % " " " & ! " 0: 3 * " & ! % ! 0 " * & *" 8 2 " & ! " ! & * " 3 ! 0 ' : * % 7 2 ; " " " 0: % " " * 0 & " " 3 ' " &" " " & " ! ' 3" 7 % & 3 " " % " % ) " " ! &2);;
(
" % " " & " ' " " " 7 7 3 " 0: 3 # ! % " & " " 8 % " &" " 2);<
'
!
; " ! % " ! % ");H
.
" 9 # " ! 8 #3 1 ' - 3 "
2 ; ' 0
! " 0 " $ -/$ &&3 3"C 5 // -$ & 15 ,$ " & / & & 9 # ! " , 6 02 =@ , 1" 1 ' , 9<@D%/ - ,/ 2 ; 9 # " ! ' 1" " % ' % 2 , 0 ' " + " , 3 ' " & ! " % 0 0 ' " 2 " 7 & ! " 0 " 6 % 1 ' &" " " 0" "7 2 1 0 1 ' " " ! &" 2
SECCIÓN V – Información presupuestaria
)<
G
.
5
B
$
Tabla V.30 Recursos necesarios (en USD)Año 1 Año 2 Año 3
(Estimado) (Estimado)Año 4 (Estimado)Año 5 Total
Recursos Humanos 186,300 183,300 157,500 147,100 148,300 822,500 Infraestructura / equipos 720,894 193,018 171,438 51,095 26,690 1,163,134 Capacitación/ Planificación 953,100 1,116,900 831,540 610,400 530,910 4,042,850 Bienes/ Productos 648,727 555,928 471,859 349,606 249,907 2,276,027 Medicamentos 1,103,030 1,058,909 954,121 761,091 457,757 4,334,908 Vigilancia y evaluación 57,480 63,480 50,240 38,590 30,470 240,260 Costos administrativos 63,780 60,780 59,265 51,133 43,000 277,958 Otros
(Por favor línea de base. Evaluación, material de oficina/capacita ción) 314,440 173,913 138,056 114,574 205,487 946,470 Total 4,047,751 3,406,227 2,834,018 2,123,588 1,692,522 14,104,107
Las categorías presupuestarias pueden incluir los siguientes ítems:
Recursos Humanos: Consultores, reclutamiento, salarios de trabajadores directos, etc. Infraestructura / equipos: instalaciones, edificios y equipos, vehículos, microscopios, etc. Capacitación / planificación: Capacitación, talleres, reuniones, etc.
Bienes / productos: Mosquiteros, preservativos, jeringas, material educativo, etc.
Medicamentos: Antiretrovirales, medicamentos para infecciones oportunistas, medicamentos para TB, medicamentos antimalaria, etc.
Vigilancia y evaluación: recolección de datos, análisis, preparación de informes, etc. Costos administrativos: Costos fijos, administración de programas, costos de auditoría, etc. Otros (por favor especificar):
)<
.
2
%
$
2
$
4
$
#
.1 (I,
J= (.1=-1
Ítem / unidad Costo unitario
(en USD) Volumen (especificar medida) Costo total (en USD) AZT + Lamibudina 1.04 320 242.944 Efavirenz 200 mg 1.11 280 340.326 ddI 100 mg 0.65 80 75.920 d4T 1.75 80 102.200 Nelfinavir 250 mg 1.4 60 275.940 Indinavir 400 mg 1.5 60 65.700 TOTAL 1.103.030
8
Tabla V.30.1Ítem / unidad Costo unitario
(en USD) Volumen (especificar medida) Costo total (en USD) Afiches 0.72 10,000 7,200 Comerciales radio 15.00 100 1,500 comerciales TV 20.00 100 2,000 Condones 4.00 8,140 32,560 Folletos 2.00 31,800 63,600 Folletos estudiantes 0.50 340,000 170,000 Formularios 8.00 3,000 24,000 Formularios de laboratorio (por 100
form) 5.00 2,200 11,000 Guantes (cajas de 100) 4.00 192 768 Guía para maestro 1.00 30,000 30,000 Guías/normas 3.00 5,000 15,000 Incentivos para donantes 0.48 40,000 19,200 Manuales de laboratorio 3.00 833 2,499
Paneles de proeficiencia 37,500
Pruebas de laboratorio 350.00 400 140,000 Tripticos/material impreso 0.50 179,000 89,500 Tubos y agujas vacutainers 0.50 4,800 2,400
Equipos
Tabla V.30.1
Ítem / unidad Costo unitario
(en USD) Volumen (especificar medida)
Costo total (en USD) Adecuación Laboratorios 6,667 3 20,000 Adecuaciones Hospitales 500 4 2,000 Camara bioseguridad nivel 2 20,000 3 60,000 Camara bioseguridad nivel 3 30,000 1 30,000 Citometro de flujo 45,000 1 45,000 Computador 1,500 51 76,500 Equipo de tamizaje: lector, lavador e
incubador 7,910 10 79,100 Equipo para Carga viral 50,000 1 50,000 Escritorio y silla 150 8 1,200 Hardware (fairware, enlace, servidor,
backup) y software 112,000 1 112,000 Impresora 350 51 17,850 Infocus 3,500 25 87,500 Lectores de microelisa 3,500 10 35,000 librero 100 8 800 Mesa y 16 sillas 1,000 8 8,000 Microscopios de inmunifluorecencia de epiluminación 20,000 3 60,000 mueble /mesa con puertas 100 8 800 refrigerador 300 8 2,400 Retroproyector 2,899 1 2,899 Silla de estracción de sangre 100 8 800
TV 625 37 23,125 VHS 160 37 5,920 TOTAL 720,894
)<)
1
D
/
!!0
$ 6
A
!!
?
2
$
?
D
@
/
?
0
; " 3 =<H " 7 3 N>H " 0 " +/9 2 " +/9 ' " " " % % " & " 2 =NH 3 0 " : 2)H
&
?
2
G
.
$
2
2
4
5
B
D
)**<$
J&'/
'
?
H)
0
Tabla V.31.1 1999 2000 2001 2002 2003 2004 2005 Internos (públicos y privados) 2.000 1.274.000 1.945.677 4.410.125 5.205.473 6.004.863 6.838.230 Externos 20.000 40.000 45.000 117.634 - - - Total 22.000 1.314.000 1.990.677 4.527.759 5.205.473 6.004.863 6.838.230)7
&
presupuesto
6 $
2 ?
3
B
$ B
' 2 ?
4
$
VER ANEXO)
1
- 2
A
?
3
$
3 /
'
?
H:
0
Tabla V.33 Asignación de recursos a asociados* (%) EjecutoresAño 1 Año 2 (Estimado) Año 3 (Estimado) Año 4 (Estimado) Año 5 Total
Gobierno (incluye
medicamentos 68.1 74.3 68.0 65.9 53.8 67.5
ONG / Org. De base
comunitaria 31.9 23.7 29.9 31.3 43.4 30.8 Sector privado
Personas que viven
con VIH/TB/malaria 2.0 2.1 2.8 2.8 1.7 Organizaciones académicas / educacionales Organizaciones de base confesional Otros (por favor especificar)
Total 100% 100% 100% 100% 100% 100%
Total en USD 4,047,751 3,406,227 2,834,018 2,123,588 1,692,522 14,104,107
SECCIÓN VI: (favor ver sección común a todos los
componentes).
SECCIÓN VII – Información de vigilancia y evaluación
:7
'
2
$/ ?
2F
0
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
análisis estadístico cruzado y comparativo de tendencias con estándares nacionales e internacionales; aplicación de métodos de muestreo para realizar estudios de validación de datos de comportamiento y satisfacción de usuarios.
:77 J K1 ! " &: " 3 '$ 0 " " ! " " " 5" # %" ! " ! ! ! " 0 0' 3 % 5 % & ! " & 5 ) 0 " & ! % " ! 0 " 02
:
6
@
2
K1$
$
$
$
Actividades (orientadas a fortalecer la
Recursos necesarios (en USD) vigilancia y
evaluación Año 1 Año 2 Año 3 Año 4 Año 5 Total
de sistemas) Asociado(s) (que pueden colaborar para fortalecer las capacidades de V&E)
Línea de base* MSP, MEC, IESS, FFAA,** ONG, Policía
200.000 200.000*
Unidades
centinela ONG, IESS, FFAA, Policía
51000 51000 51000 51000 51000 255.000 Estudios de Seroprevalencia y comportamiento ONG de HSH, Asociaciones de TS, ONG que trabajan con HSH y TS, Policía. 61000 61.000 Recolección de información - Capacitación de personal MSP, ONG, MEC, IESS, FFAA, ONG. Policía. 193380 193380 386.760 Análisis y difusion
de la información MSP, MEC, IESS, FFAA , INEC, registro Civil, ONG, Policía,
5000 5000 5000 5000 5000 25.000
Seguimiento MSP, MEC, IESS, FFAA , INEC, registro Civil, ONG, Policía, 27500 27500 27500 27500 27500 137.500 Evaluación final 100.000 100.000* Total requerido al Fondo Mundial 227.000 27.500 27.500 27.500 127.500 437.500 Total de otros recursos disponibles 249.380 56.000 310.380 56.000 56.000 727.760
* Cifras ya incluidas en el presupuesto solicitado al Fondo global.
** MEC. Ministerio de Educación MSP: Ministerio de Salud
IESS: Instituto de Seguridad Social FFAA: Fuerzas Armadas
